Expertise in
25
conditions

Stephane Jouneau

Rennes, FR 
Expertise in
25
conditions
Rennes, FR 

Overview

Stephane Jouneau practices practicing medicine in Rennes, France.

Ms. Jouneau is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant.

She is actively involved in clinical research, co-authoring 211 peer reviewed articles and participating in 8 clinical trials.

Gender

Female

Locations

Rennes, 35000, France
Other Locations
CHU de Rennes, Rennes
Bretagne, France
Clermont-ferrand, France
CHU Bordeaux
Bordeaux, France
Paris, France
Poitiers, France
Basseux, France
Nantes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Pneumocystis Pneumonia Diagnosis in HIV- Patients: Assessment of the Real Time Polymerase Chain Reaction Quantification on Oropharyngeal Rinse
Pneumocystis Pneumonia Diagnosis in HIV- Patients: Assessment of the Real Time Polymerase Chain Reaction Quantification on Oropharyngeal Rinse
Enrollment Status: Completed
Publish Date: June 15, 2026
Intervention Type: Other
Study Phase: Not Applicable
Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Biological
Study Phase: Not Applicable
Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial
Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial
Enrollment Status: Completed
Publish Date: February 09, 2026
Intervention Type: Drug
Study Drug: Pirfenidone
Study Phase: Phase 4
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis
SARCOLOWDOSE : Ultra-low Dose CT Scan and MRI in Thoracic Sarcoidosis
Enrollment Status: Completed
Publish Date: May 17, 2023
Intervention Type: Other
Study Phase: Not Applicable
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Drug, Device
Study Phase: Phase 2
View 7 Less Clinical Trials

211 Total Publications

Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study).
Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study).
Journal: Respiratory research
Published: March 23, 2026

Frequently Asked Questions about Stephane Jouneau

Is Stephane Jouneau a top-rated expert for Acute Interstitial Pneumonia?

MediFind is an objective health platform that identifies experts based on real-world data. Stephane Jouneau is classified as an Elite expert for Acute Interstitial Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stephane Jouneau participate in research or clinical trials?

Yes. Stephane Jouneau has published 211 articles and abstracts on conditions like Acute Interstitial Pneumonia. You can view a list of Stephane Jouneau's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Jouneau's expertise for a condition
ConditionClose
View All 17 Advanced Conditions
View All 42 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile